Brief: Annovis Bio Secures US Patent For Buntanetap To Treat Acute Traumatic Brain Injury
24/07/2024 14:00
July 24 (Reuters) - Annovis Bio Inc ANVS.N :
* ANNOVIS BIO SECURES U.S. PATENT FOR TREATMENT OF ACUTE
TRAUMATIC
BRAIN INJURY WITH BUNTANETAP
Source text for Eikon: ID:nGNX5mCbHN
Further company coverage: ANVS.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Annovis Bio
See all newsAnnovis Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Annovis Bio Q2 loss widens as R&D costs rise
Annovis Bio Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants
U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman